 |
|
The Importance of the Journal Embargo
Phil B. Fontanarosa, MD;
Catherine D. DeAngelis, MD, MPH
JAMA. 2002;288:748-750.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The major goal of THE JOURNAL is to publish the very best articles possible to advance medical science and expand medical knowledge, thereby enabling physicians and other health care professionals to provide the most up-to-date, scientific, evidence-based care for patients. The recently published report from the National Heart, Lung, and Blood Institute (NHLBI) Women's Health Initiative (WHI)1 illustrates the importance of providing solid evidence from rigorously conducted clinical trials that has the potential to change clinical practice—in this case, involving use of estrogen-plus-progestin hormone therapy. Moreover, the unexpected findings of the WHI investigation, that this major primary prevention trial was stopped early because the risks of combination estrogen-plus-progestin therapy outweighed the benefits for postmenopausal women, have implications for millions of women taking hormone therapy. Thus, it was virtually inevitable that the study results would generate intense interest among clinicians and widespread . . . [Full Text of this Article]
Author Affiliations: Dr Fontanarosa is Executive Deputy Editor and Dr DeAngelis is Editor, JAMA.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
When Does Previous Disclosure Become a 'Prior Publication' Problem?
Langdon-Neuner
Chest 2009;135:233-237.
FULL TEXT
Update on JAMA's Policy on Release of Information to the Public
Fontanarosa et al.
JAMA 2008;300:1585-1587.
FULL TEXT
Coronary Calcium Screening and the American Heart Association News Embargo
Loscalzo et al.
Circulation 2004;110:3504-3505.
FULL TEXT
|
